Percutaneous Coronary Intervention Pharmacology: From a Triangle to a Square
- 19 February 2008
- journal article
- editorial
- Published by Elsevier BV in Journal of the American College of Cardiology
- Vol. 51 (7), 698-700
- https://doi.org/10.1016/j.jacc.2007.10.042
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- Periprocedural Bleeding and 1-Year Outcome After Percutaneous Coronary InterventionsJournal of the American College of Cardiology, 2008
- Predictors and Impact of Major Hemorrhage on Mortality Following Percutaneous Coronary Intervention from the REPLACE-2 TrialThe American Journal of Cardiology, 2007
- Variation in the definitions of bleeding in clinical trials of patients with acute coronary syndromes and undergoing percutaneous coronary interventions and its impact on the apparent safety of antithrombotic drugsAmerican Heart Journal, 2007
- Impact of Major Bleeding on 30-Day Mortality and Clinical Outcomes in Patients With Acute Coronary SyndromesJournal of the American College of Cardiology, 2007
- Clopidogrel Use and Long-term Clinical Outcomes After Drug-Eluting Stent ImplantationJAMA, 2007
- Adverse Impact of Bleeding on Prognosis in Patients With Acute Coronary SyndromesCell Metabolism, 2006
- Correlates and outcomes of retroperitoneal hemorrhage complicating percutaneous coronary interventionCatheterization and Cardiovascular Interventions, 2006
- A Comparison of the Clinical Impact of Bleeding Measured by Two Different Classifications Among Patients With Acute Coronary SyndromesJournal of the American College of Cardiology, 2006
- Relationship of Blood Transfusion and Clinical Outcomes in Patients With Acute Coronary SyndromesJAMA, 2004
- Differential mortality risk of postprocedural creatine kinase-MB elevation following successful versus unsuccessful stent proceduresJournal of the American College of Cardiology, 2004